#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

bilaterální karcinom prsu

Proton Therapy and Its Results in the Treatment of Bilateral Breast Cancer

11. 5. 2023 Source: Proton Radiotherapy

Breast cancer is the most common malignant tumor disease in women, and its incidence sharply increases after the age of 50. Although its incidence shows a continuously increasing trend, the development of mortality is more favorable. Thanks to nationwide screening and more successful therapy, mortality has long been stable, even slightly decreasing. A relatively rare variant of this oncological disease is primary synchronously detected bilateral breast cancer (PSBBC). Experts from the Proton Therapy Center in Prague are focusing on the use of…

obvaz doctor

Compression Therapy with Zinc Oxide Dressings in Dermatology

Zinc oxide dressings have a long-standing tradition and continue to find their place in modern…
10. 5. 2023 Source: Wound Healing
pacient hlava

Metamizole in Pain Management for Patients with Subarachnoid Hemorrhage

A study by Czech authors from the University Hospital St. Anna in Brno, recently published in the …
10. 5. 2023 Source: Analgesia
orto kartacek

Comparison of the Effectiveness of Different Types of Toothbrushes in Orthodontic Patients

The aim of the study cited below was to evaluate the efficiency of a manual orthodontic brush, an…
10. 5. 2023 Source: Dental Care
RS

Efficacy and Safety of Ozanimod in the Treatment of Relapsing-Remitting MS

The sphingosine-1-phosphate receptor (S1PR) modulator ozanimod has recently been approved for the…
9. 5. 2023 Source: Modulation of S1P in the Treatment of Autoimmune Diseases
ulcerozni__kolitida

Ozanimod Expands Treatment Options for Ulcerative Colitis in Adult Patients

As a review article published last year in the journal Drugs suggests, ozanimod is an effective and…
9. 5. 2023 Source: Modulation of S1P in the Treatment of Autoimmune Diseases
Ulcerozni_kolitida

Ozanimod in Induction and Maintenance Therapy for Ulcerative Colitis − True North Study Results

Ozanimod is a selective modulator of the sphingosine-1-phosphate receptor (S1PR) approved for the…
9. 5. 2023 Source: Modulation of S1P in the Treatment of Autoimmune Diseases
Chemoterapie_žena a lékař

Prognostic Significance of Mutations in Maintenance Hypomethylation Therapy for AML Patients

A recently published sub-analysis of the QUAZAR AML-001 clinical trial evaluated the efficacy of…
9. 5. 2023 Source: Acute Myeloid Leukemia
AML

Current Recommendations by the ELN Expert Panel on AML Diagnosis Management

The 2022 recommendations from European LeukemiaNet (ELN) add new information to the previous…
9. 5. 2023 Source: Acute Myeloid Leukemia
kev

Overuse of Corticosteroids as a Serious Problem in ITP

Corticosteroids (CS) are a common part of the treatment for immune thrombocytopenia (ITP). However,…
9. 5. 2023 Source: Immune Thrombocytopenia
1 31 32 33 34 35 158
Filter by speciality
Remove filters

Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#